Analysis of Volatile Organic Compounds

Aetna considers analysis of volatile organic compounds experimental and investigational and therefore does not cover it for uses including detection of bacteriuria, detection of bronchiolitis obliterans syndrome in lung transplant recipients, detection of various cancers (e.g., bladder, breast, colorectal, esophagogastric, gastric, hepatobiliary, gallbladder, leukemia/lymphoma, lung/pleural, pancreatic, renal) and diagnosis/monitoring of pleural mesothelioma. No indications are specified and the key requirement for coverage—established clinical effectiveness—is not met.

"Aetna considers the analysis of volatile organic compounds experimental and investigational for the following indications (not an all-inclusive list) because the clinical effectiveness of this tech..."

Sign up to see full coverage criteria, indications, and limitations.